Christopher J. Cassella is an associate in the Intellectual Property Litigation practice at Goodwin. He started at the firm in 2022. Mr. Cassella concentrates his legal practice in representing pharmaceutical companies in complex pharmaceutical patent litigation matters arising under the Hatch-Waxman Amendments to the Patent Act and the Federal Food, Drug and Cosmetic Act.

While in law school, in addition to five CALI Excellence for the Future Awards (given to the highest-scoring student in each law school class), Mr. Cassella earned Brief Writing Honors in the Sherman Minton Moot Court Competition. He also served on the Executive Board of his law school's Intellectual Property Association and was a Senior Editor of the law school's journal, IP Theory. He has an advanced degree in biology as well as an undergraduate degree in biochemistry.

Mr. Cassella is registered to practice in patent matters before the U.S. Patent and Trademark Office. He is admitted to practice in Illinois only. His practice is supervised by D.C.-admitted lawyers at Goodwin.

Areas of Practice
业务范围
Domaines D’Expertise
TÄTIGKEITSFELDER

Experience

工作经历

EXPÉRIENCE

ERFAHRUNG

Mr. Cassella’s experience ranges from pre-litigation activities, including Paragraph IV Certifications, through initial filings, fact and expert discovery, claim construction, pre-trial, trial, and post-trial phases.

His representative matters include:

  • Represented generic drug manufacturer in Hatch-Waxman litigation concerning oral formulations of cystic fibrosis transmembrane conductance regulator potentiator indicated for the treatment of cystic fibrosis*
  • Represented generic drug manufacturer in Hatch-Waxman litigation concerning oral formulations of an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis*
  • Represented generic drug manufacturer in Hatch-Waxman litigation concerning oral formulations of a dipeptidyl peptidase-4 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus*
  • Represented generic drug manufacturer in Hatch-Waxman litigation concerning oral formulations of a sodium-glucose cotransporter inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus*
  • Represented generic drug manufacturer in Hatch-Waxman litigation concerning oral formulations of an antidepressant indicated for the treatment of major depressive disorder*
  • Represented generic drug manufacturer in Hatch-Waxman litigation concerning oral formulations of endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension*
  • Represented generic drug manufacturer in Hatch-Waxman litigation concerning oral formulations of a combination of an aromatic amino acid decarboxylation inhibitor and an aromatic amino acid indicated for the treatment of Parkinson's disease*
  • Represented generic drug manufacturer in Hatch-Waxman litigation concerning oral formulations of atypical antipsychotic indicated for the treatment of schizophrenia and depressive episodes associated with Bipolar I Disorder*
*Denotes experience prior to joining Goodwin.
Professional Experience
Prior to joining Goodwin, Mr. Cassella was an Associate in the IP Pharmaceutical & Biotechnology practice group at Locke Lord LLP.
Professional Activities
  • American Intellectual Property Law Association
  • Chicago Bar Association
  • Chicago Volunteer Legal Services, Junior Board Member (April 2020 – Present)
  • St. Procopius Legal Aid Clinic, Chair (July 2019 – February 2022)

Recognition

  • Top ANDA Litigator, ANDA Litigation Intelligence Report (2021)
  • Distinguished Service Award, Chicago Volunteer Legal Services (2019)

Credentials

专业资格

RÉFÉRENCES

WERDEGANG

Education

J.D., 2017
Indiana University Maurer School of Law
(magna cum laude)
M.S., Biology, 2012
Indiana University – Purdue University Indianapolis
B.A., Biochemistry, 2011
DePauw University

Admissions

Bar

Illinois
U.S. Patent and Trademark Office
Profile Image
Get In Touch
联系我们
NOUS CONTACTER
Kontakt
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
搜寻其他律师
Recherche par Pratique
ANWALTSSUCHE